Categories: News

Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life

SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers significant enhancements, including an extended shelf life, improved ease of use, and streamlined preparation, directly addressing critical feedback from physician users.

- Advertisement -

The highly anticipated Sniper G3 features a 24-month shelf life, doubling the longevity of its predecessor. This improvement offers greater inventory flexibility for hospitals and clinics. Designed with direct input from interventional radiologists, Sniper G3 also features improved trackability and a simplified preparation process, significantly reducing pre-procedure setup time. The new prep method eliminates several steps, cutting preparation time down to less than a minute, a crucial gain in fast-paced clinical environments. This focus on user feedback underscores Embolx’s commitment to developing intuitive, high-performance tools that enhance clinical workflow.

- Advertisement -

Sniper G3 truly exemplifies our dedication to innovation driven by physician needs,” said Michael Allen, President and CEO of Embolx. “We listened intently to our users and engineered a device that not only extends product longevity and improves performance, but also significantly enhances the ease of use, which translates directly to more efficient procedures. We are incredibly proud of Sniper G3 and its potential to set a new standard in embolization therapy.”

- Advertisement -

The Sniper G3 Balloon Occlusion Microcatheter represents a significant leap forward in Embolx’s commitment to physician-centric innovation. It is available in all standard lengths and is ready for worldwide distribution.

- Advertisement -

About Embolx
Embolx has pioneered advanced pressure-mediated delivery of therapeutics directly into cancerous tumors, prostates, and other anatomical structures and is dedicated to transforming healthcare through the development of innovative technologies.

- Advertisement -

For media inquiries, please contact:

- Advertisement -

Haley McGregor
Global Marketing and Sales Operations Manager
hmcgregor@embolx.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2738641/Sniper_g3_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/embolx-launches-sniper-g3-revolutionizing-embolization-with-enhanced-efficiency-ease-of-use-and-extended-shelf-life-302514310.html

- Advertisement -

Recent Posts

Canara HSBC Life Insurance Celebrates Father’s Day with a Heartwarming Tribute to Dad Jokes

The digital film highlights how fathers express love through humour, turning everyday moments into lifelong…

13 minutes ago

Hong Kong Brings the PUMA HYROX World Championships to the APAC Region for the First Time in 2027

Imagery HereHONG KONG, June 20, 2026 /PRNewswire/ -- HYROX has officially announced that Hong Kong will…

13 minutes ago

Remote People Named Best Employer of Record (EOR) Platform in G2 Summer 2026 Reports, Earning 80+ Badges Across Global Employment Categories

G2 names Remote People a Leader in Employer of Record (EOR), Global Employment Platforms, and…

13 minutes ago

Invitation to attend the extraordinary shareholders meeting of the Company to be held on July 9, 2026

REGULATED INFORMATIONJune 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue Edouard…

2 hours ago

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 19, 2026 16:05 ET  | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., June 19, 2026 (GLOBE…

2 hours ago